The structural profiles are close, with BioMarin Pharmaceutical carrying a narrow edge on growth. Shopify still leads on growth and profitability, which keeps the comparison from looking entirely one-sided. The market setup broadly confirms the structural lead — BioMarin Pharmaceutical holds the more constructive position. That puts structure and market broadly in agreement — BioMarin Pharmaceutical's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (BMRN: Russell 1000, SHOP: Nasdaq 100).
On growth, the clearer edge sits with Shopify Inc., while the overall score remains tighter and points the other way.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
The match is driven mainly by revenue stability and investment intensity.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Shopify Inc. occupies the cheaper side of the setup map, although BioMarin Pharmaceutical Inc. still holds the stronger structural profile.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where BMRN and SHOP each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The main growth separation is very wide, driven by a meaningfully stronger expansion profile.
Capital efficiency also runs the other way, with a 18.4-point ROIC edge acting as a real counterforce.
The lead is built on both growth and stability — though growth still provides a counterweight.
Break down the BMRN vs SHOP comparison across all dimensions with the full interactive tool.
Explore how BMRN and SHOP each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.